Transforming Pediatric Oncology – The Power of Precision Medicine
This session brings together a hand-selected panel of experts to showcase innovations shaping the future of pediatric oncology. Topics include bioinformatics, proteomics, genomics, and immunotherapy, with a clear focus on translating discovery into clinical practice.
Designed to spark a dynamic discussion, the session will explore current practices, identify translational gaps, and point to future directions—highlighting how precision medicine can transform outcomes for children with cancer.
Free attendance and complimentary 12.00 CE/CME & MOC credits are available for this in-person conference.
Session Highlights
- Advances across bioinformatics, proteomics, genomics & immunotherapy
- Translational pathways: from discovery to bedside
- Case-driven discussion on practice change and impact
- Future directions for pediatric precision oncology
Who Should Attend
- Pediatric oncologists & hematologists
- Translational researchers & clinical scientists
- Bioinformaticians & molecular pathologists
- Pharma/biotech teams advancing pediatric therapies
Trademark notice: ASCO® and American Society of Clinical Oncology® are registered trademarks of the American Society of Clinical Oncology, Inc., used with permission. This is not an ASCO-sponsored event.
This session is part of the Advancing Precision Medicine event series.